Table 4.
Results of the mixed logistic regression predicting for which cases more than one option was recommended (N = 185 cases in 28 sessions)
| Predictor | Full model | Stepwise model | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| Dermatological vs. gyn. MDTM | 0.95 | 0.01 to 93.97 | .981 | |||
| Gastrointestinal vs. gyn. MDTM | 288.58 | 0.28 to >999.00 | .109 | 7.36 | 1.38 to 39.35 | .020** |
| Head and neck cancer vs. gyn. MDTM | 1.94 | 0.17 to 22.07 | .593 | |||
| Liver and biliary tract vs. gyn. MDTM | 1.99 | 0.20 to 19.57 | .552 | |||
| Lymphoma and myeloma vs. gyn. MDTM | 4.85 | 0.17 to 135.52 | .351 | |||
| Neuro-oncological vs. gyn. MDTM | 2.81 | 0.12 to 68.75 | .524 | 5.39 | 1.24 to 23.45 | .025** |
| Non-entity-specific oncological vs. gyn. MDTM | 5.45 | 0.08 to 386.63 | .433 | |||
| Non-entity-specific surgical vs. gyn. MDTM | 14.44 | 0.29 to 730.38 | .181 | |||
| Thorax vs. gyn. MDTM | 1.28 | 0.00 to >999.00 | .944 | |||
| Uro-oncological vs. gyn. MDTM | 21.27 | 0.31 to >999.00 | .154 | |||
| Number of attending professionals (1 person increase) | 0.90 | 0.71 to 1.13 | .352 | |||
| Duration of session (10 min increase) | 0.82 | 0.36 to 1.84 | .630 | |||
| Number of cases discussed in this session (1 case increase) | 1.20 | 0.82 to 1.76 | .347 | |||
| Quality of case historya | 0.64 | 0.02 to 26.76 | .813 | |||
| Quality of radiological informationa | 0.74 | 0.39 to 1.41 | .359 | |||
| Quality of information on comorbiditiesa | 1.12 | 0.79 to 1.59 | .532 | |||
| Presentation of whether case was palliative (dichotomous variable) | 0.52 | 0.11 to 2.42 | .399 | |||
| Quality of psychosocial informationa | 0.95 | 0.57 to 1.60 | .836 | |||
| Quality of information on the patient’s views and preferencesa | 1.10 | 0.72 to 1.69 | .661 | |||
| Number of active participants in the discussion of each individual case (1 person increase) | 0.89 | 0.60 to 1.33 | .571 | |||
| Quality of chair behaviora | 1.24 | 0.68 to 2.26 | .704 | |||
| Quality of team behaviora | 1.32 | 0.58 to 3.01 | .508 | |||
| Medical and treatment uncertainty during case discussiona | 2.12 | 1.39 to 3.23 | .001** | 2.16 | 1.48 to 3.14 | <.001** |
| Duration of case discussion (1 min increase) | 1.13 | 0.94 to 1.43 | .203 | |||
OR Odds ratio, CI Confidence interval, gyn gynecological
Bold typesetting of OR indicates statistical significance
*Indicates p < .10
**Indicates p < .05
aIndicates 1 step increase